Adage Capital Partners Portfolio holdings
AUM
$66.1B
1-Year Est. Return
38.05%
This Fund
S&P 500
1 Year Est. Return
+38.05%
AUM
$66.1B
AUM Growth
+$2.93B
(+4.6%)
Holding
1,051
Top Buys
| 1 | +$153M | |
| 2 | +$150M | |
| 3 | +$129M | |
| 4 |
ConocoPhillips
COP
|
+$99.9M |
| 5 |
Revolution Medicines
RVMD
|
+$95.9M |
Top Sells
| 1 | +$262M | |
| 2 | +$229M | |
| 3 | +$174M | |
| 4 |
Procter & Gamble
PG
|
+$142M |
| 5 |
ETNB
89bio
ETNB
|
+$134M |
Sector Composition
| 1 | Technology | 29.25% |
| 2 | Healthcare | 15.27% |
| 3 | Financials | 12.07% |
| 4 | Communication Services | 9.26% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
lululemon athletica
LULU
$19.5B
| $22.3M | 0.03% |
107,400
+8,100
|
|
||
|
APXT
452
Apex Treasury Corp
APXT
$458M
| $22.3M | 0.03% |
+2,250,000
|
|
||
453
iRhythm Holdings
IRTC
$3.9B
| $22.2M | 0.03% |
125,000
+75,000
|
|
||
454
Bio-Techne
TECH
$8.26B
| $22M | 0.03% |
373,236
+230,536
|
|
||
455
Kodiak Sciences
KOD
$1.53B
| $21.9M | 0.03% |
785,000
-550,000
|
|
||
456
Immunovant
IMVT
$5.23B
| $21.9M | 0.03% |
863,000
+519,400
|
|
||
457
Newmark Group
NMRK
$2.56B
| $21.9M | 0.03% |
1,265,000
+215,000
|
|
||
|
CHYM
458
Chime Financial
CHYM
$8.48B
| $21.9M | 0.03% |
868,785
+84,834
|
|
||
459
Willis Towers Watson
WTW
$27.3B
| $21.8M | 0.03% |
66,488
+20,700
|
|
||
|
BETA
460
Beta Technologies Inc
BETA
$4.58B
| $21.7M | 0.03% |
+770,689
|
|
||
461
Advanced Drainage Systems
WMS
$11.7B
| $21.7M | 0.03% |
150,000
-84,000
|
|
||
462
Four Corners Property Trust
FCPT
$2.81B
| $21.7M | 0.03% |
940,000
+240,000
|
|
||
463
Crane NXT
CXT
$2.59B
| $21.6M | 0.03% |
459,396
+94,985
|
|
||
464
Universal Display
OLED
$4.55B
| $21.6M | 0.03% |
185,000
+100,000
|
|
||
465
Hewlett Packard
HPE
$28B
| $21.4M | 0.03% |
891,236
-28,400
|
|
||
466
Nova
NVMI
$13.7B
| $21.3M | 0.03% |
65,000
+35,000
|
|
||
467
Dollar General
DG
$32.1B
| $21.1M | 0.03% |
158,700
+91,400
|
|
||
468
SouthState Bank Corp
SSB
$9.18B
| $21.1M | 0.03% |
223,800
|
|
||
469
Arbutus Biopharma
ABUS
$906M
| $20.9M | 0.03% |
4,339,941
-675,000
|
|
||
470
Edison International
EIX
$27.4B
| $20.9M | 0.03% |
347,404
-2,900
|
|
||
471
Confluent
CFLT
$11B
| $20.8M | 0.03% |
+686,717
|
|
||
472
Relmada Therapeutics
RLMD
$485M
| $20.6M | 0.03% |
+4,270,000
|
|
||
473
Crown Holdings
CCK
$11.9B
| $20.6M | 0.03% |
+200,000
|
|
||
474
Pentair
PNR
$14.7B
| $20.6M | 0.03% |
+197,702
|
|
||
475
LXP Industrial Trust
LXP
$2.81B
| $20.6M | 0.03% |
415,000
+85,000
|
|